Benjamin L. Palleiko
2022
In 2022, Benjamin L. Palleiko earned a total compensation of $3.4M as President, Chief Business Officer and Chief Financial Officer at Carbylan Therapeutics, a 135% increase compared to previous year.
Compensation breakdown
| Bonus | $220,500 |
|---|---|
| Option Awards | $1,361,595 |
| Salary | $490,000 |
| Stock Awards | $1,346,625 |
| Other | $12,333 |
| Total | $3,431,053 |
Palleiko received $1.4M in option awards, accounting for 40% of the total pay in 2022.
Palleiko also received $220.5K in bonus, $490K in salary, $1.3M in stock awards and $12.3K in other compensation.
Rankings
In 2022, Benjamin L. Palleiko's compensation ranked 1,052nd out of 5,760 executives tracked by ExecPay. In other words, Palleiko earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,052 out of 5,760 | 82nd |
Division Manufacturing | 492 out of 3,136 | 84th |
Major group Chemicals And Allied Products | 178 out of 1,422 | 88th |
Industry group Drugs | 159 out of 1,323 | 88th |
Industry Pharmaceutical Preparations | 118 out of 969 | 88th |
Source: SEC filing on August 14, 2023.
Palleiko's colleagues
We found two more compensation records of executives who worked with Benjamin L. Palleiko at Carbylan Therapeutics in 2022.